Current management and recommendations for access to antiviral therapy of herpes labialis
- 1 January 2012
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 53 (1) , 6-11
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebo-controlled, patient-initiated clinical trialJournal of the American Academy of Dermatology, 2011
- Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and ManagementAntimicrobial Agents and Chemotherapy, 2011
- Over the counter medicines: proceed with cautionBMJ, 2008
- A survey on the prevalence of orofacial herpes in France: The INSTANT StudyJournal of the American Academy of Dermatology, 2006
- Single-dose, patient-initiated famciclovir: A randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialisJournal of the American Academy of Dermatology, 2006
- Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based surveySexually Transmitted Infections, 2006
- Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled TrialClinical Infectious Diseases, 2006
- FamciclovirDrugs, 2006
- Oral acyclovir in prevention of herpes labialisOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1998
- The Natural History of Recurrent Herpes Simplex LabialisNew England Journal of Medicine, 1977